Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (5)
Oncogene (2)
Bone Marrow Transplantation (2)
British Journal of Cancer (1)
Nature Biotechnology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (8)
Correspondence (2)
Reviews (2)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biotechnology
Computational biology and bioinformatics
Diseases

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–13 of 13 results

Advanced filters: Author: I Breitkreutz Clear advanced filters

Keratin 16 and keratin 17 mutations cause pachyonychia congenita

W.H.I. McLean
E.L. Rugg
C.S. Munro
Research01 Mar 1995
Nature Genetics

Volume: 9, P: 273-278
SAINT: probabilistic scoring of affinity purification–mass spectrometry data

A statistical framework for assigning confidence scores for protein-protein interaction data generated via affinity purification–mass spectrometry, called significance analysis of interactome (SAINT) is described.

Hyungwon Choi
Brett Larsen
Alexey I Nesvizhskii
Research05 Dec 2010
Nature Methods

Volume: 8, P: 70-73
Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer

M L Friedlander
P Russell
M H Tattersall
Research01 Mar 1985
British Journal of Cancer

Volume: 51, P: 319-333
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield

I Breitkreutz
H M Lokhorst
H Goldschmidt
Research22 Mar 2007
Leukemia

Volume: 21, P: 1294-1299
ProHits: integrated software for mass spectrometry–based interaction proteomics

Guomin Liu
Jianping Zhang
Anne-Claude Gingras
Correspondence13 Oct 2010
Nature Biotechnology

Volume: 28, P: 1015-1017
Bortezomib inhibits human osteoclastogenesis

I von Metzler
H Krebbel
O Sezer
Research21 Jun 2007
Leukemia

Volume: 21, P: 2025-2034
Targeted treatments to improve stem cell outcome: old and new drugs

M S Raab
I Breitkreutz
K C Anderson
Reviews03 Sept 2007
Bone Marrow Transplantation

Volume: 40, P: 1129-1137
Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells

L J Nicholson
P Hopwood
D H Crawford
Research17 Jul 1997
Oncogene

Volume: 15, P: 275-283
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure

I Breitkreutz
C Heiss
M S Raab
Research04 Aug 2014
Bone Marrow Transplantation

Volume: 49, P: 1371-1375
Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes

Curt Wittenberg
Steven I Reed
Reviews18 Apr 2005
Oncogene

Volume: 24, P: 2746-2755
Erratum: Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

I Breitkreutz
M S Raab
K C Anderson
Amendments and Corrections15 Oct 2008
Leukemia

Volume: 22, P: 1973
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

M C Minnema
I Breitkreutz
H M Lokhorst
Correspondence07 Oct 2004
Leukemia

Volume: 18, P: 2044-2046
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

I Breitkreutz
M S Raab
K C Anderson
Research03 Jul 2008
Leukemia

Volume: 22, P: 1925-1932